NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA,
JAPAN, AUSTRALIA, HONG KONG OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN
WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS
ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED
HEREIN

Reference is made to the stock exchange announcement published by Atlantic
Sapphire ASA (the "Company" or "Atlantic Sapphire") on 20 August 2024 regarding
the contemplated underwritten rights issue in the Company (the "Rights Issue"),
and to the stock exchange notice published on 13 September 2024 regarding, among
other things, revised proposals to the extraordinary general meeting. Updated
key information relating to the Rights Issue is set out below. 

o	Date on which the terms and conditions of the Rights Issue were announced: 20
August 2024
o	Last day including right: 17 September 2024 
o	Ex-date: 18 September 2024 
o	Record Date: 19 September 2024 
o	Date of approval: 17 September 2024 
o	Maximum number of new shares: 6,844,800,000
o	Subscription price: NOK 0.10 
o	Ratio preferential rights: 61.0552 subscription per 1 existing share in the
Company registered as held as of the Record Date. The aggregate number of
subscription rights granted to each shareholder as of the Record Date will be
rounded down to the nearest whole subscription right.
o	Subscription ratio: 1:1 (1 subscription right will give the right to subscribe
1 new share in the Rights Issue)
o	Managers: Arctic Securities AS and DNB Markets, a part of DNB Bank ASA 
o	Will the rights be listed: Yes 
o	ISIN for the preferential rights: NO 001 3336222
o	Other information: The subscribers in the Rights Issue will receive (free of
charge) one warrant for each two shares subscribed in the Rights Issue. Warrants
will also be granted to underwriters in the Rights Issue and to lenders in a
convertible loan to be raised in conjunction with the Rights Issue, see separate
stock exchange notice from the Company dated 20 August 2024. The Company will
seek to ensure that the Warrants are admitted to trading on Oslo Børs as soon as
possible following completion of the Rights Issue, but there can be no assurance
that such admittance to trading will be obtained.

For further information, please contact: 

Gunnar Aasbø-Skinderhaug, Atlantic Sapphire ASA, Deputy CEO/ CFO 
Gunnar@atlanticsapphire.com

Investorrelations@atlanticsapphire.com

About Atlantic Sapphire ASA:

Atlantic Sapphire is pioneering Bluehouse® (land-raised) salmon farming,
locally, and transforming protein production, globally. Atlantic Sapphire
operated its innovation center in Denmark from 2011 until 2021 with a strong
focus on R&D and innovation to equip the Company with the technology and
procedures that enable the Company to commercially scale up production in end
markets close to the consumer. 

In the US, the Company holds the requisite permits and patents to construct its
Bluehouse® in an ideal location in Homestead, Florida, just south of Miami. The
Company's Phase 1 facility is in operation, which provides the capacity to
harvest up to approximately 9,500 tons (HOG) of salmon annually. The Company
completed its first commercial harvest in the US in September 2020. Atlantic
Sapphire is currently constructing its Phase 2 expansion, which will bring total
annual production capacity to 25,000 tons and has a long-term targeted harvest
volume of 220,000 tons.

This information is published in accordance with the requirements of the
Continuing Obligations.